EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Advances in Nano-Drug Delivery Strategies for Chalcogen–Based Therapeutic Agents in Cancer Phototherapy

Subhrakant Jena iD, Abderrazzak Douhal iD

International Journal of Molecular Sciences · 17.05.2025 · 26 (10) · 4819

DOI: 10.3390/ijms26104819 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.05.2025. Verfasst von Subhrakant Jena und 1 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Química Física, Facultad de Ciencias Ambientales y Bioquímica, and INAMOL, Universidad de Castilla-La Mancha, Avenida Carlos III, 450…. Hauptthemen laut MEDLINE: Neoplasms, Chalcogens, Photosensitizing Agents, Drug Delivery Systems. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MICIU/AEI/10.13039/501100011033, European Union, Junta de Comunidades de Castilla la Mancha.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chalcogen–containing therapeutic agents (TAs), which include sulfur (S), selenium (Se), and tellurium (Te) atoms, have recently emerged as a promising class of photosensitizers (PSs) and photothermal agents (PTAs) for cancer phototherapy. The incorporation of heavier chalcogens into organic chromophores leads to visible–to–near–infrared (VIS–NIR) light absorption, efficient triplet harvesting, and adequate heat and energy transfer efficiency, all of which are paramount for photodynamic therapy (PDT) and photothermal therapy (PTT). However, chalcogen–based PSs/PTAs suffer from photostability, bioavailability, and targeted delivery issues, which minimize their PDT/PTT performances. Nevertheless, significant progress in the rational design of nanoencapsulation strategies has been achieved to overcome the challenges of chalcogen–based TAs for effective phototherapeutic cancer treatment. This review highlights the recent advances (within the last five years) in nano-drug delivery approaches adapted for chalcogen–substituted PSs/PTAs for PDT, PTT, or synergistic PDT/PTT, integrating imaging and treatment. The PSs/PTAs described in this review are classified into three classes: (i) sulfur, (ii) selenium, and (iii) tellurium–containing TAs used in phototherapy applications. This review offers a comprehensive perspective on the design of chalcogen–substituted photosensitizers (PSs) and photothermal agents (PTAs), covering spectroscopic and computational characterization, nanoformulation strategies, and their roles in enhancing reactive oxygen species (ROS) generation and photothermal conversion efficiency for improved in vitro and in vivo performance. We hope this work will encourage further research into nanotechnological strategies designed to enhance the phototherapeutic efficacy of chalcogen–containing therapeutic agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsChalcogensPhotosensitizing AgentsDrug Delivery SystemsPhototherapyNanoparticle Drug Delivery SystemAntineoplastic AgentsHumansPhotochemotherapyAnimalsSeleniumPhotothermal TherapyNanoparticles

Stichwörter der Autor:innen

cancer therapychalcogennano-drug deliveryphotodynamic therapyphotothermal therapyreactive oxygen speciestriplet harvesting

Substanzen

ChalcogensPhotosensitizing AgentsSeleniumNanoparticle Drug Delivery SystemAntineoplastic Agents

Autor:innen und Institutionen

  • Departamento de Química Física, Facultad de Ciencias Ambientales y Bioquímica, and INAMOL, Universidad de Castilla-La Mancha, Avenida Carlos III, 45071 Toledo, Spain.

ORCID-Profile: Subhrakant Jena, Abderrazzak Douhal

Förderung

  • MICIU/AEI/10.13039/501100011033
  • European Union
  • Junta de Comunidades de Castilla la Mancha
  • UCLM
  • European Union (EU) NextGenerationEU (PRTR-C17.I1)
  • “Junta de Comunidades de Castilla la Mancha” (JCCM) and the EU through “Fondo Europeo de Desarrollo Regional” (FEDER)

Zitieren

APA

Jena, S., & Douhal, A. (2025). Recent Advances in Nano-Drug Delivery Strategies for Chalcogen–Based Therapeutic Agents in Cancer Phototherapy. International Journal of Molecular Sciences, 26(10), 4819. https://doi.org/10.3390/ijms26104819

Vancouver

Jena S, Douhal A. Recent Advances in Nano-Drug Delivery Strategies for Chalcogen–Based Therapeutic Agents in Cancer Phototherapy. International Journal of Molecular Sciences. 2025;26(10):4819. doi:10.3390/ijms26104819

BibTeX
@article{Jena2025,
  author = {Jena, Subhrakant and Douhal, Abderrazzak},
  title = {Recent Advances in Nano-Drug Delivery Strategies for Chalcogen–Based Therapeutic Agents in Cancer Phototherapy},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {10},
  pages = {4819},
  doi = {10.3390/ijms26104819}
}
Kostenlos starten →